Sign-up for our newsletter to stay up-to-date with ManukaMed news

    

Frequently Asked Questions

Frequently Asked Questions

ManukaMed medical grade Manuka honey wound care dressings are highly effective in closing difficult and chronic wounds, and healing wounds in less time. In most cases, the effect of our Manuka honey can be seen at the first dressing change. In moderate to highly exudative wounds, the HD line shows immediate management of exudate and maintains a moist wound environment.  Click here for before and after wound closure photos of actual patient cases.

ManukaMed wound care sterile single-use dressings are indicated for leg ulcers, pressure ulcers, 1st and 2nd degree burns (superficial and partial thickness), diabetic foot ulcers, surgical wounds, traumatic wounds, skin tears, and skin grafts including the donor site.

ManukaMed medical grade honey wound dressings should be applied at the commencement of wound treatment through to closure completion. For most chronic wounds, application should occur after surgical debridement on day 1 of the post sharp debridement process. Manuka honey is exceptional as a maintenance debridement system by inhibiting the Plasmin Activator Inhibitor (PAI) and allowing more natural plasmin into the wound bed. Patients gain the special bioactive properties including the anti-inflammatory and antimicrobial protection of Manuka honey throughout treatment.

ManukaMed wound care products are USFDA cleared as sterile single-use 510(k) medical devices. ManukaMed employs other internal quality standards to ensure that the highest and most consistent medical grade honey is delivered in every dressing.

Please contact ManukaMed at 800-881-3654, or email to ussales@manukamed.com.

During the first week of use the dressings should be changed every 1 to 3 days, then as needed. Nurses can assess when the dressing is fully absorbed and change at this time. MEDSAF and MANUKAhd Superlite should be changed daily.

Manuka honey (Leptospermum scoparium) from ManukaMed is a high potency medical grade honey. It is superior to other medical grade honeys as measured by the methylglyoxal concentration and anti-bacterial activity. ManukaMed produces its own honey from a monoclonal source for consistency, owns over 30,000 bee hives in Manuka forest in New Zealand, and has proprietary processes and quality controls to produce its medical grade honey and wound dressings. ManukaMed is ISO certified for medical devices.

ManukaMed Leptospermum scoparium honey wound dressings are superior in anti-bacterial activity to other honey wound dressings and versus silver gel in vitro, as proven by 17 randomized clinical trials and published peer-reviewed papers. ManukaMed honey dressings also have no known resistance to any pathogen and is not cytotoxic as some silver dressings are. Because Manuka honey is not ionic, it can be used in and with hyperbaric oxygen therapy.

ManukaMed Leptospermum scoparium honey wound dressings have a high sugar content which reduces wound bed odor.

ManukaMed USA is a wholly owned subsidiary of ManukaMed Inc. of New Zealand. The US headquarters is located in Franklin, Tennessee, and the warehouse/distribution center is in Kansas City, MO.